Quick browse by jurisdictions
Directory
Robert H Fischer is chairman of the firm’s licensing and transactions practice group. He has been practising IP law for over 30 years for clients in a wide variety of technological fields, including computers, semiconductors and biotechnology. He has an extensive practice in licensing, opinion work and counselling, in complex interferences and litigation, and in procuring patent protection in software, electronics, mechanical devices and systems and other fields. Mr Fischer has also represented clients in connection with the IP aspects of major corporate transactions, including joint venture formations, refinancings and sales of businesses.
Mr Fischer has served as chair of the New York Intellectual Property Law Association Financial Industry Committee. Mr Fischer has also provided legal assistance to, and is a senior advisory board member of, Voices of September 11th, an organisation providing support in response to the 9/11 attacks and advocacy for public policy reform pertaining to terrorism. Mr Fischer was also counsel of record for the American Intellectual Property Law Association before the US Supreme Court in Pfaff v Wells Electronics, Inc.
Prior to going to law school, Mr Fischer was an engineer at the General Electric Company, Sunnyvale, California, where he was involved in the design of liquid metal fast breeder nuclear reactors.
Mr Fischer received his JD from the University of California, Berkeley in 1979. He was an editor of the California Law Review and graduated Order of the Coif. He holds a master’s in engineering from Stanford University, awarded in 1974, and a BS in engineering from Cooper Union, awarded in 1973. He is a member of Tau Beta Pi (national engineering honour society).
He has written articles and lectured extensively over the years on intellectual property and licensing.
1290 Avenue of the Americas
New York NY
10104
United States
E: rfischer@fchs.com
T: +1 212 218 2254
F: +1 212 218 2200
W:
www.fitzpatrickcella.com
Isolated DNA sequence patents - safe for now in the US
Issue 56
A divided panel of the US Court of Appeals for the Federal Circuit confirmed that isolated natural DNA sequences
remain patentable in the United States. But this may not be the final word on the subject